/Research Database
← Research Database
ModeratRCT2026

Dietary supplementation with 25-hydroxycholecalciferol is more effective than cholecalciferol in improving reproductive performance in aged duck breeders.

Yating Li, Yongyan Jin, Lei Zhuang, Wei Zhou et al.

Kernaussage

Dietary supplementation with 25-hydroxycholecalciferol (25-OH-D3) is more effective than cholecalciferol (VD3) in improving egg production, hatchability, and ovarian development in aged duck breeders, with a relative bioavailability of 211% based on plasma concentrations.

Abstract

This study aimed to evaluate the effects of supplementing two vitamin D sources on reproductive performance, egg quality, and plasma biochemical indices of aged duck breeders, and to estimate vitamin D requirements and relative bioavailability from these two sources. A total of 180 laying Pekin ducks (64 wk of age) were randomly assigned to 9 different treatments, each containing 10 replicates with 2 birds per replicate. The birds were fed a basal diet with no vitamin D supplementation or supplemented with cholecalciferol (VD3) or 25-hydroxycholecalciferol (25-OH-D3) at 250, 500, 1000, or 2000 IU/kg of feed for 15 wk. The two-way ANOVA (2 × 4 factors, without a control group) and one-way ANOVA were employed to compare the differences between 25-OH-D3 and VD3. In comparison to ducks fed the basal diet, the egg production (9 to 15 wks), ovarian weight, and the number and weight of dominant follicles increased with increasing VD3 or 25-OH-D3 levels (linear and quadratic, P < 0.05). The egg Haugh unit exhibited a linear increase with rising VD3 levels (P = 0.021) and a quadratic increase with rising 25-OH-D3 levels (P = 0.042). Additionally, the plasma calcium content increased linearly as dietary 25-OH-D3 levels increased (P = 0.001). Furthermore, diets supplemented with 25-OH-D3 resulted in higher plasma 25-OH-D3 concentrations compared to those fed VD3 (P < 0.001). According to the quadratic broken-line model, the VD3 requirements of duck breeders in terms of enhancing egg production, ovarian weight, and dominant follicle number were 906, 359, and 730 IU/kg, respectively, whereas the 25-OH-D3 requirements were 260, 324, and 308 IU/kg, respectively. Based on slope ratio comparison from multiple linear regressions of ovarian weight, dominant follicle number, and plasma 25-OH-D3 concentration, the bioavailability of 25-OH-D3 were 147%, 191%, and 211%, respectively, relative to VD3. During the late laying period, the egg production and egg quality of breeding ducks decline. This decline adversely affects egg hatchability and the health of the offspring, ultimately reducing economic benefits. Vitamin D3 (VD3) plays a significant role in modulating reproductive performance. However, the endogenous synthesis of VD3 in breeding ducks is insufficient to meet their requirements, necessitating dietary supplementation. The National Research Council (NRC 1994) proposed a dietary level of 900 IU/kg of VD3 for duck breeders; however, this recommendation lacks supporting literature. 25-Hydroxycholecalciferol (25-OH-D3) is the principal circulating form of VD3 in the bloodstream and is more readily utilized than VD3. However, the efficacy of 25-OH-D3 compared to VD3 during the late laying period of breeding ducks remains uncertain. Therefore, this study aimed to evaluate the effects of supplementing two vitamin D sources on reproductive performance, egg quality, and plasma biochemical indices of aged duck breeders, as well as to estimate vitamin D requirements and relative bioavailability from these two sources. The results indicated that the efficacy of 25-OH-D3 in enhancing ovarian weight, ovarian index, both the number and weight of dominant follicle, and 25-OH-D3 plasma content surpassed that of VD3. Supplementing the basal diet with 906 IU/kg VD3 or 324 IU/kg 25-OH-D3 is recommended for aged duck breeders, and the bioavailability of 25-OH-D3 relative to VD3 is 211%.

Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.

Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.

Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.